Professionals 98 results
Capabilities 28 results
Industry
Industry
Practice Area
Experience 5 results
Experience
|April 23, 2025
Voyager Acquisition Corp. and VERAXA Biotech Announce Business Combination
Experience
|January 29, 2025
Drugs Made In America Acquisition Corp. Announces Closing of $200,000,000 Initial Public Offering
Experience
|December 20, 2021
ACON Investments' Acquisition of Vitalis Group
Insights & News 382 results
Global Trade & Foreign Policy Insights
|May 30, 2025
|4 Min Read
On May 28, 2025, the U.S. Court of International Trade (CIT) ruled as unlawful two types of tariffs imposed by President Trump through executive orders implemented under the International Emergency Economic Powers Act (IEEPA).
Benefits Blast
|May 30, 2025
|6 Min Read
Health and Welfare Roundup – 4 Developments Plan Sponsors Should Be Aware of This Month
While recent regulatory developments—including the Departments’ nonenforcement policy, proposed legislation, and new transparency rules—offer employers and plan fiduciaries greater flexibility and potential relief, they also underscore the need for continued vigilance. From ensuring compliance with longstanding MHPAEA obligations to evaluating benefit design changes, managing PBM relationships, and addressing nondiscrimination concerns in self-funded plans, stakeholders must stay proactive and informed to navigate the evolving health and welfare benefits landscape effectively.While recent regulatory developments—including the Departments’ nonenforcement policy, proposed legislation, and new transparency rules—offer employers and plan fiduciaries greater flexibility and potential relief, they also underscore the need for continued vigilance. From ensuring compliance with longstanding MHPAEA obligations to evaluating benefit design changes, managing PBM relationships, and addressing nondiscrimination concerns in self-funded plans, stakeholders must stay proactive and informed to navigate the evolving health and welfare benefits landscape effectively.
Investigations, Enforcement, & Compliance Alerts
|May 20, 2025
|10 Min Read
Rebalancing the Sticks and the Carrots? A New DOJ White-Collar Enforcement Plan
Given the recent changes the Trump Administration has made at the Department of Justice (DOJ),many people have wondered when a formal change to the DOJ’s white-collar prosecution policies, particularly the corporate self-disclosure policy, might come. During remarks at a Financial Crimes Conference on May 12, Matthew Galeotti, the new Head of the DOJ’s Criminal Division, announced some of the changes to the DOJ’s policies, starting with the new commitment to be less “heavy-handed with the stick, and [less] stingy with the carrot.”
Other Results 35 results
Law Glossary
Law Glossary
What Is the Approval Process for Generic Drugs?
Law Glossary
What Is the Standard for the FDA to Grant a Generic Drug License?